The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination
Open accessAbstract
BACKGROUND: The heterogeneity of malaria transmission makes widespread elimination a difficult goal to achieve. Most of the current vector control measures insufficiently target outdoor transmission. Also, insecticide resistance threatens to diminish the efficacy of the most prevalent measures, indoor residual spray and insecticide treated nets. Innovative approaches are needed. The use of endectocides, such as ivermectin, could be an important new addition to the toolbox of anti-malarial measures. Ivermectin effectively targets outdoor transmission, has a novel mechanism of action that could circumvent resistance and might be distributed over the channels already in place for the control of onchocerciasis and lymphatic filariasis. METHODS: The previous works involving ivermectin and Anopheles vectors are reviewed and summarized. A review of ivermectin's safety profile is also provided. Finally three definitive clinical trials are described in detail and proposed as the evidence needed for implementation. Several smaller and specific supportive studies are also proposed. CONCLUSIONS: The use of ivermectin solves many challenges identified for future vector control strategies. It is an effective and safe endectocide that was approved for human use more than 25 years ago. Recent studies suggest it might become an effective and complementary strategy in malaria elimination and eradication efforts; however, intensive research will be needed to make this a reality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Ranson, H., N’Guessan, R., Lines, J., Moiroux, N., Nkuni, Z., & Corbel, V. (2011) · Trends in Parasitology · doi:10.1016/j.pt.2010.08.004 · Cited by 1,142
Malaria: progress, perils, and prospects for eradication
Greenwood, B. M., Fidock, D. A., Kyle, D. E., Kappe, S. H. I., Alonso, P. L., Collins, F. H., & Duffy, P. E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33996 · Cited by 709
Self-citationThe changing epidemiology of malaria elimination: New strategies for new challenges
Cotter, C., Sturrock, H. J., Hsiang, M. S., Liu, J., Phillips, A. A., Hwang, J., Gueye, C. S., Fullman, N., Gosling, R. D., & Feachem, R. G. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60310-4 · Cited by 671
Multiple-Insecticide Resistance in Anopheles gambiae Mosquitoes, Southern Côte d’Ivoire
Edi, C. V. A., Koudou, B. G., Jones, C. M., Weetman, D., & Ranson, H. (2012) · Emerging Infectious Diseases · doi:10.3201/eid1809.120262 · Cited by 250 · cited 1×
“The first challenge is developing a broader range of insecticides with novel modes of action to counter current insecticide resistance among Anopheles species [10].”
BackgroundKelly-Hope, L. A., & McKenzie, F. E. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-19 · Cited by 203 · cited 2×
“Since then, more than a 1.5 billion treatments have been distributed in Africa and Latin America for onchocerciasis control and another 665 million for treatment of lymphatic filariasis [15].”
BackgroundInfluential
Cited by
Characterizing, controlling and eliminating residual malaria transmission
Killeen, G. F. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-330 · Cited by 506
Oral, ultra–long-lasting drug delivery: Application toward malaria elimination goals
Bellinger, A. M., Jafari, M., Grant, T. M., Zhang, S., Slater, H. C., Wenger, E. A., Mo, S., Lee, Y.-A. L., Mazdiyasni, H., Kogan, L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag2374 · Cited by 262
Developing an expanded vector control toolbox for malaria elimination
Killeen, G. F., Tatarsky, A., Diabate, A., Chaccour, C. J., Marshall, J. M., Okumu, F. O., Brunner, S., Newby, G., Williams, Y. A., Malone, D., et al. (2017) · BMJ Global Health · doi:10.1136/bmjgh-2016-000211 · Cited by 149
Self-citationPriorities for Broadening the Malaria Vector Control Tool Kit
Barreaux, P., Barreaux, A. M. G., Sternberg, E. D., Suh, E., Waite, J. L., Whitehead, S. A., & Thomas, M. B. (2017) · Trends in Parasitology · doi:10.1016/j.pt.2017.06.003 · Cited by 67
Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery
Marques, J., Valle-Delgado, J. J., Urbán, P., Baró, E., Prohens, R., Mayor, A., Cisteró, P., Delves, M., Sinden, R. E., Grandfils, C., et al. (2017) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2016.09.010 · Cited by 64
Metadata
- Authors
- Chaccour, C. J., Kobylinski, K. C., Bassat, Q., Bousema, T., Drakeley, C., Alonso, P., & Foy, B. D.
- Venue
- Malaria Journal
- Published
- 2013-05-07
- Volume
- 12
- Issue
- 1
- Pages
- 153-153
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2094341907
- Cited by
- 181
- References
- 6
- FWCI
- 13.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. https://app.cochat.ai/papers/10.1186/1475-2875-12-153
- The paper
- Chaccour, C. J., Kobylinski, K. C., Bassat, Q., Bousema, T., Drakeley, C., Alonso, P., & Foy, B. D. (2013). Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malaria Journal. https://doi.org/10.1186/1475-2875-12-153
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.